Lv11
40 积分 2024-01-31 加入
CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML
5小时前
求助中
Fungal-derived cellobiose metabolic pathway fuels T cells to bypass intratumoral glucose competition
14天前
已完结
Disulfide-Directed Multicyclic Peptides for Chimeric Antigen Receptors Targeting Solid Tumors
16天前
已完结
Deep generative models design mRNA sequences with enhanced translational capacity and stability
23天前
已完结
Venetoclax in biomarker‐selected multiple myeloma patients: Impact of exposure on clinical efficacy and safety
24天前
已完结
Venetoclax or placebo in combination with bortezomib and dexamethasone in relapsed or refractory multiple myeloma (BELLINI): final overall survival results from a randomised, phase 3 study
24天前
已完结
Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial
24天前
已完结
AI-mediated immunotherapeutics in adenoid cystic carcinoma: Challenges and current perspectives
24天前
已完结
Standard-of-care idecabtagene vicleucel for relapsed/refractory multiple myeloma
1个月前
已关闭
Equecabtagene Autoleucel in Patients With Relapsed or Refractory Multiple Myeloma
1个月前
已完结
皖公网安备34019202002308
